Roche Advances Skin Cancer Trials As Part Of Combination Therapy Strategy
Roche is pressing ahead with two skin cancer trials that combine its immunotherapy Tecentriq with other drugs after early data…
Roche is pressing ahead with two skin cancer trials that combine its immunotherapy Tecentriq with other drugs after early data…
U.S. health regulators on Friday said they have granted accelerated approval to Roche Holding’s drug for advanced lung cancer in…